Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Immune-based therapy for chronic hepatitis C
Journal of Leukocyte Biology, 07/02/09
Chang DY et al. - These immune-based therapies for chronic HCV infection include therapeutic vaccines, antagonists of T cell inhibitory factors, anti-HCV neutralizing antibodies, cytokines, and agonists for TLRs. Currently, various types of immune-based therapies are under development that might be used as a monotherapy or in combination with other antiviral drugs for the treatment of chronic HCV infection.
Related Articles
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany
Journal of Clinical Virology, 11/16/09
Relevance Score: 91%
Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09
Relevance Score: 91%
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 91%
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09
Relevance Score: 91%
FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09
Relevance Score: 91%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles
Journal of Viral Hepatitis, 11/25/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/25/09
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy
Journal of Viral Hepatitis, 11/25/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey
BMC Infectious Diseases, 11/25/09
Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection
Mucosal Immunology, 11/24/09
Coverage and Predictors of Adherence to Influenza Vaccination among Spanish Children and Adults with Asthma
Infection, 11/23/09
Article Search
Sponsor


See Latest Articles


